Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01307267
Title A Study Of PF-05082566 As A Single Agent And In Combination With Rituximab
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Pfizer
Indications

head and neck squamous cell carcinoma

diffuse large B-cell lymphoma

follicular lymphoma

Advanced Solid Tumor

non-Hodgkin lymphoma

melanoma

lung non-small cell carcinoma

B-cell lymphoma

renal cell carcinoma

Therapies

Rituximab + Utomilumab

Utomilumab

Age Groups: senior | adult
Covered Countries USA | ITA | FRA | AUS


No variant requirements are available.